Interferon α-associated retinopathy in patients with chronic hepatitis C;Interferon-α-assoziierte retinopathie bei patienten mit chronischer hepatitis C

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 11, 2005, Pages 915-918

  Schmidt, Stephanie ^a,b   Pleyer, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE   (Germany)

Author keywords

Interferon; Retinopathy

Indexed keywords

ALPHA2 INTERFERON; GLYCOPROTEIN; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BLEPHARITIS; BLOOD TOXICITY; CASE REPORT; CONJUNCTIVITIS; FEMALE; HEPATITIS C; HUMAN; IMMUNOMODULATION; IRITIS; KERATITIS; LIVER TOXICITY; NEPHROTOXICITY; PATIENT MONITORING; RETINA NEOVASCULARIZATION; RETINOPATHY; SIDE EFFECT; SYSTEMIC THERAPY; XEROPHTHALMIA;

EID: 29144526779     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858842     Document Type: Article

References (17)

1. Bauherz G, Soeur M, Lustmann F. Oculomotor nerve paralysis induced by alpha-2 Interferon. Acta Neurolog Belg 1990; 90: 11-114
2. Gabler B, Kroher G, Bogenrieder T et al. Schwerer beidseitiger Sehverlust bei malignem Melanom der Haut. Ophthalmologe 2001; 98: 672-673
3. Guyer DR, Tiedeman J, Lwarence A et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356
4. Ikebe T, Nakatuska K, Goto M et al. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn 1990; 41: 2291-2296
5. Ikeda T. Interferon-associated retinopathy and cystoid macular edema. Arch Ophthalmol 2001; 119: 1077-1079
6. Jain K, Lam WC, Waheeb S et al. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001; 85: 1171-1173
7. Kadayifcilar S, Boyacioglu S, Kart H et al. Ocular complications with high-dose interferon alfa in chronic active hepatitis. Clin Trial 1999; 13 (Pt2) (-HD): 241-246
8. Klein JB, Scherzer JA, McLeish KR. Interferon gamma enhances superoxide production by HL-60 cells stimulated with multiple agonists. J Interferon Res 1991; 11: 69-74
9. Nadir A, Amin A, Chalisa N et al. Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature. Journal of Viral Hepatitis 2000; 7: 466-470
10. Nishiguchi S, Shiomi S, Enomoto M et al. Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C? J. Gastroenterol 2001; 36: 486-491
11. Norica F, di Maria A, Prandini F et al. Natural interferon therapy: Optic nerve ischemic damage. Ophthalmologica 1999; 213: 339-340
12. Ockenfels HM, Lisch W. Übersicht zur Interferon-Nebenwirkungen am Auge bei adjuvanter Melanomtherapie. Hautarzt 2003; 54: 144-147
13. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alpha. Arch Ophthalmol 1995; 113: 1041-1044
14. Schulman JA, Liang C, Kooragayala LM et al. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmol 2003; 110: 437-442
15. Taylor JL, Grossberg SE. The effects of interferon α - on the production and action of other cytokines. Semin Oncol 1998; 25 (Suppl): 23-29
16. Tsolakos A, Zalatimo N. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment. Optometry 2003; 74: 517-523
17. Zegans ME, Anninger W, Chapman C et al. Ocular manifestations of hepatitis C virus infection. Curr Opin Ophthalmol 2002; 13: 423-427